Vault-13

Verdad Advisers, LP

BOSTON, MA · CIK 1812822 · 13F filing filed 2026-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$104.4m reported value +17.5% vs Q1 2026
210positions
18.1%in top 10
97 new 59 added 42 reduced 66 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 APPLE INC COM AAPL AAPL 7,445 $2.2m2.06% 2.06% NewShares held: Q3 2025 —, Q4 2025 4.2k, Q1 2026 0, Q2 2026 7.4k
2 BELITE BIO INC SPONSORED ADS BLTE BLTE 13,758 $2.1m2.03% 2.03% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 13.8k, Q2 2026 13.8k -55 -55 -0.4%
3 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 82,629 $2.1m2.00% 2.00% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 68.3k, Q2 2026 82.6k +14.3k +14,339 21.0%
4 COMCAST CORP NEW CL A CMCSA CMCSA 84,569 $2.1m1.99% 1.99% AddedShares held: Q3 2025 —, Q4 2025 98.4k, Q1 2026 41.5k, Q2 2026 84.6k +43.0k +43,020 103.5%
5 CHATHAM LODGING TR COM CLDT CLDT 140,000 $1.9m1.77% 1.77% UnchangedShares held: Q3 2025 —, Q4 2025 115.0k, Q1 2026 140.0k, Q2 2026 140.0k
6 TENAX THERAPEUTICS INC COM NEW TENX TENX 123,174 $1.8m1.72% 1.72% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 95.3k, Q2 2026 123.2k +27.8k +27,844 29.2%
7 SLIDE INS HLDGS INC COM SLDE SLDE 91,070 $1.8m1.69% 1.69% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 30.7k, Q2 2026 91.1k +60.4k +60,412 197.1%
8 ZYMEWORKS INC COM ZYME ZYME 66,688 $1.7m1.67% 1.67% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 82.7k, Q2 2026 66.7k -16.0k -16,010 -19.4%
9 AMN HEALTHCARE SVCS INC COM AMN AMN 51,906 $1.7m1.61% 1.61% AddedShares held: Q3 2025 —, Q4 2025 45.0k, Q1 2026 50.0k, Q2 2026 51.9k +1.9k +1,906 3.8%
10 X4 PHARMACEUTICALS INC COM NEW XFOR XFOR 352,093 $1.6m1.57% 1.57% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 352.1k
11 VERSANT MEDIA GROUP INC COM CL A VSNT VSNT 43,503 $1.6m1.50% 1.50% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 19.0k, Q2 2026 43.5k +24.5k +24,506 129.0%
12 NETSCOUT SYS INC COM NTCT NTCT 33,128 $1.4m1.38% 1.38% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 14.7k, Q2 2026 33.1k +18.4k +18,406 125.0%
13 AADI BIOSCIENCE INC COM WHWK WHWK 301,483 $1.4m1.32% 1.32% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 115.5k, Q2 2026 301.5k +186.0k +185,999 161.1%
14 JOHNSON & JOHNSON COM JNJ JNJ 5,384 $1.4m1.31% 1.31% ReducedShares held: Q3 2025 —, Q4 2025 17.4k, Q1 2026 5.4k, Q2 2026 5.4k -34 -34 -0.6%
15 CONTINEUM THERAPEUTICS INC CL A CTNM CTNM 81,014 $1.3m1.27% 1.27% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 86.0k, Q2 2026 81.0k -5.0k -5,018 -5.8%
16 JADE BIOSCIENCES INC COM NEW JBIO JBIO 56,384 $1.3m1.20% 1.20% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 56.4k
17 CISCO SYS INC COM CSCO CSCO 10,307 $1.2m1.16% 1.16% NewShares held: Q3 2025 —, Q4 2025 29.9k, Q1 2026 0, Q2 2026 10.3k
18 NURIX THERAPEUTICS INC COM NRIX NRIX 49,511 $1.2m1.15% 1.15% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 83.4k, Q2 2026 49.5k -33.9k -33,914 -40.6%
19 PROTARA THERAPEUTICS INC COM STK TARA TARA 312,249 $1.2m1.14% 1.14% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 312.2k
20 BLOOMIN BRANDS INC COM BLMN BLMN 130,000 $1.2m1.14% 1.14% AddedShares held: Q3 2025 —, Q4 2025 100.0k, Q1 2026 100.0k, Q2 2026 130.0k +30.0k +30,000 30.0%
21 TYRA BIOSCIENCES INC COM TYRA TYRA 36,003 $1.1m1.10% 1.10% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 36.0k
22 PAR PAC HOLDINGS INC COM NEW PARR PARR 20,000 $1.1m1.07% 1.07% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 22.5k, Q2 2026 20.0k -2.5k -2,500 -11.1%
23 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 27,234 $1.1m1.06% 1.06% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 13.1k, Q2 2026 27.2k +14.2k +14,182 108.7%
24 ALPHABET INC CAP STK CL A GOOGL GOOGL 2,900 $1.0m0.99% 0.99% NewShares held: Q3 2025 —, Q4 2025 8.5k, Q1 2026 0, Q2 2026 2.9k
25 CARTERS INC COM CRI CRI 25,000 $1.0m0.99% 0.99% UnchangedShares held: Q3 2025 —, Q4 2025 20.0k, Q1 2026 25.0k, Q2 2026 25.0k
26 VERA THERAPEUTICS INC CL A VERA VERA 23,487 $1.0m0.97% 0.97% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 10.2k, Q2 2026 23.5k +13.3k +13,306 130.7%
27 NUVALENT INC COM COM 8,104 $1.0m0.96% 0.96% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 8.1k
28 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 10,062 $980.8k0.94% 0.94% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 8.7k, Q2 2026 10.1k +1.4k +1,363 15.7%
29 ACLARIS THERAPEUTICS INC COM ACRS ACRS 175,272 $927.2k0.89% 0.89% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 197.0k, Q2 2026 175.3k -21.8k -21,770 -11.1%
30 OPPENHEIMER HLDGS INC CL A NON VTG OPY OPY 8,673 $915.3k0.88% 0.88% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 3.4k, Q2 2026 8.7k +5.3k +5,252 153.5%
31 VERIZON COMMUNICATIONS INC COM VZ VZ 20,938 $886.5k0.85% 0.85% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 20.9k
32 MYERS INDS INC COM MYE MYE 24,500 $865.1k0.83% 0.83% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 24.5k
33 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 16,957 $860.6k0.82% 0.82% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 17.0k
34 UNIVERSAL INS HLDGS INC COM UVE UVE 20,558 $850.3k0.81% 0.81% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 20.6k
35 BANK NEW YORK MELLON CORP COM BNY BNY 5,748 $831.2k0.80% 0.80% ReducedShares held: Q3 2025 —, Q4 2025 14.8k, Q1 2026 9.0k, Q2 2026 5.7k -3.2k -3,203 -35.8%
36 PC CONNECTION INC COM CNXN CNXN 11,084 $809.0k0.77% 0.77% NewShares held: Q3 2025 —, Q4 2025 8.2k, Q1 2026 0, Q2 2026 11.1k
37 AMERICAN INTEGRITY INS GROUP COM AII AII 42,178 $794.2k0.76% 0.76% AddedShares held: Q3 2025 —, Q4 2025 37.5k, Q1 2026 41.1k, Q2 2026 42.2k +1.1k +1,083 2.6%
38 APPLIED MATLS INC COM AMAT AMAT 1,089 $787.3k0.75% 0.75% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 2.9k, Q2 2026 1.1k -1.8k -1,805 -62.4%
39 ADAPTHEALTH CORP COMMON STOCK AHCO AHCO 75,000 $781.5k0.75% 0.75% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 95.0k, Q2 2026 75.0k -20.0k -20,000 -21.1%
40 ALLSTATE CORP COM ALL ALL 3,279 $780.2k0.75% 0.75% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 3.3k
41 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 20,704 $770.4k0.74% 0.74% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 20.7k
42 REVOLUTION MEDICINES INC COM RVMD RVMD 4,053 $759.0k0.73% 0.73% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 21.6k, Q2 2026 4.1k -17.5k -17,519 -81.2%
43 HERITAGE INSURANCE HLDGS INC COM HRTG HRTG 28,575 $745.2k0.71% 0.71% AddedShares held: Q3 2025 —, Q4 2025 28.8k, Q1 2026 26.5k, Q2 2026 28.6k +2.1k +2,081 7.8%
44 TD SYNNEX CORPORATION COM SNX SNX 2,780 $743.2k0.71% 0.71% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 1.4k, Q2 2026 2.8k +1.3k +1,334 92.2%
45 MOVADO GROUP INC COM MOV MOV 18,762 $737.5k0.71% 0.71% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 10.7k, Q2 2026 18.8k +8.0k +8,019 74.6%
46 SMART SAND INC COM SND SND 142,684 $714.8k0.68% 0.68% AddedShares held: Q3 2025 —, Q4 2025 101.0k, Q1 2026 122.7k, Q2 2026 142.7k +20.0k +19,988 16.3%
47 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 38,722 $711.3k0.68% 0.68% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 31.2k, Q2 2026 38.7k +7.5k +7,543 24.2%
48 DESIGN THERAPEUTICS INC COM DSGN DSGN 47,557 $688.1k0.66% 0.66% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 92.3k, Q2 2026 47.6k -44.8k -44,753 -48.5%
49 MARCUS & MILLICHAP INC COM MMI MMI 21,972 $684.9k0.66% 0.66% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 15.5k, Q2 2026 22.0k +6.4k +6,433 41.4%
50 MATIV HOLDINGS INC COM MATV MATV 90,000 $681.3k0.65% 0.65% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 90.0k
51 STONEX GROUP INC COM SNEX SNEX 5,682 $673.3k0.64% 0.64% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 6.9k, Q2 2026 5.7k -1.3k -1,265 -18.2%
52 CYTOMX THERAPEUTICS INC COM CTMX CTMX 176,407 $661.5k0.63% 0.63% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 30.2k, Q2 2026 176.4k +146.2k +146,220 484.4%
53 NET LEASE OFFICE PROPERTIES COM NLOP NLOP 58,791 $654.3k0.63% 0.63% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 23.9k, Q2 2026 58.8k +34.9k +34,862 145.7%
54 GERON CORP COM GERN GERN 494,201 $632.6k0.61% 0.61% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 494.2k
55 OOMA INC COM OOMA OOMA 32,810 $630.6k0.60% 0.60% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 19.3k, Q2 2026 32.8k +13.5k +13,484 69.8%
56 ROCKY BRANDS INC COM RCKY RCKY 15,254 $629.1k0.60% 0.60% AddedShares held: Q3 2025 —, Q4 2025 15.0k, Q1 2026 15.0k, Q2 2026 15.3k +254 +254 1.7%
57 JANUX THERAPEUTICS INC COM JANX JANX 40,386 $620.3k0.59% 0.59% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 40.4k
58 ZOOM COMMUNICATIONS INC CL A ZM ZM 7,125 $615.0k0.59% 0.59% ReducedShares held: Q3 2025 —, Q4 2025 20.9k, Q1 2026 21.6k, Q2 2026 7.1k -14.5k -14,455 -67.0%
59 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 11,335 $608.3k0.58% 0.58% UnchangedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 11.3k, Q2 2026 11.3k
60 AVALO THERAPEUTICS INC COM NEW AVTX AVTX 32,827 $606.6k0.58% 0.58% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 32.8k
61 MISTRAS GROUP INC COM MG MG 34,526 $603.2k0.58% 0.58% UnchangedShares held: Q3 2025 —, Q4 2025 50.0k, Q1 2026 34.5k, Q2 2026 34.5k
62 VIEMED HEALTHCARE INC COM VMD VMD 52,879 $602.8k0.58% 0.58% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 52.9k
63 RELMADA THERAPEUTICS INC COM RLMD RLMD 86,994 $602.0k0.58% 0.58% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 47.1k, Q2 2026 87.0k +39.8k +39,845 84.5%
64 CLIMB BIO INC COM CLYM CLYM 46,115 $601.3k0.58% 0.58% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 144.5k, Q2 2026 46.1k -98.4k -98,425 -68.1%
65 CORBUS PHARMACEUTICALS HLDGS COM NEW CRBP CRBP 63,603 $596.6k0.57% 0.57% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 50.3k, Q2 2026 63.6k +13.4k +13,351 26.6%
66 BRISTOL-MYERS SQUIBB CO COM BMY BMY 10,263 $591.4k0.57% 0.57% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 10.3k
67 SECURITY NATL FINL CORP CL A NEW SNFCA SNFCA 60,000 $581.4k0.56% 0.56% UnchangedShares held: Q3 2025 —, Q4 2025 80.8k, Q1 2026 60.0k, Q2 2026 60.0k
68 USANA HEALTH SCIENCES INC COM USNA USNA 26,068 $556.6k0.53% 0.53% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 17.1k, Q2 2026 26.1k +9.0k +8,994 52.7%
69 TALKSPACE INC COM TALK TALK 105,252 $547.3k0.52% 0.52% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 175.6k, Q2 2026 105.3k -70.3k -70,299 -40.0%
70 NVIDIA CORPORATION COM NVDA NVDA 2,735 $547.2k0.52% 0.52% NewShares held: Q3 2025 —, Q4 2025 6.3k, Q1 2026 0, Q2 2026 2.7k
71 UROGEN PHARMA LTD COM URGN URGN 14,440 $531.4k0.51% 0.51% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 14.4k
72 ATAIBECKLEY INC COM SHS ATAI ATAI 100,681 $530.6k0.51% 0.51% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 227.7k, Q2 2026 100.7k -127.0k -126,989 -55.8%
73 CALIFORNIA RES CORP COM STOCK CRC CRC 10,000 $528.7k0.51% 0.51% ReducedShares held: Q3 2025 —, Q4 2025 7.2k, Q1 2026 22.5k, Q2 2026 10.0k -12.5k -12,500 -55.6%
74 CULLINAN THERAPEUTICS INC COM CGEM CGEM 28,987 $527.9k0.51% 0.51% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 12.6k, Q2 2026 29.0k +16.4k +16,383 130.0%
75 IBIO INC COM NEW IBIO IBIO 298,927 $523.1k0.50% 0.50% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 56.3k, Q2 2026 298.9k +242.6k +242,609 430.8%
76 VIATRIS INC COM VTRS VTRS 32,500 $516.1k0.49% 0.49% UnchangedShares held: Q3 2025 —, Q4 2025 65.0k, Q1 2026 32.5k, Q2 2026 32.5k
77 INNOVAGE HLDG CORP COM INNV INNV 42,139 $499.3k0.48% 0.48% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 31.6k, Q2 2026 42.1k +10.5k +10,498 33.2%
78 HELLO GROUP INC ADS MOMO MOMO 84,685 $491.2k0.47% 0.47% ReducedShares held: Q3 2025 —, Q4 2025 109.2k, Q1 2026 149.3k, Q2 2026 84.7k -64.6k -64,568 -43.3%
79 PMV PHARMACEUTICALS INC COM PMVP PMVP 362,361 $485.6k0.47% 0.47% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 180.2k, Q2 2026 362.4k +182.2k +182,200 101.1%
80 NATIONAL HEALTHCARE CORP COM NHC NHC 2,295 $485.1k0.46% 0.46% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 2.3k
81 CIRRUS LOGIC INC COM CRUS CRUS 3,265 $484.9k0.46% 0.46% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 3.2k, Q2 2026 3.3k +28 +28 0.9%
82 MICRON TECHNOLOGY INC COM MU MU 419 $483.6k0.46% 0.46% ReducedShares held: Q3 2025 —, Q4 2025 6.8k, Q1 2026 3.8k, Q2 2026 419 -3.4k -3,422 -89.1%
83 JONES LANG LASALLE INC COM JLL JLL 1,552 $481.0k0.46% 0.46% ReducedShares held: Q3 2025 —, Q4 2025 690, Q1 2026 3.2k, Q2 2026 1.6k -1.6k -1,611 -50.9%
84 APA CORPORATION COM APA APA 14,562 $474.3k0.45% 0.45% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 14.6k
85 RMR GROUP INC CL A RMR RMR 22,496 $461.8k0.44% 0.44% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 22.5k
86 FULCRUM THERAPEUTICS INC COM FULC FULC 125,224 $458.3k0.44% 0.44% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 125.2k
87 PROG HOLDINGS INC COM NPV PRG PRG 9,382 $437.3k0.42% 0.42% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 22.3k, Q2 2026 9.4k -12.9k -12,917 -57.9%
88 SEPTERNA INC COM SEPN SEPN 12,970 $434.4k0.42% 0.42% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 13.0k
89 BIOAGE LABS INC COM BIOA BIOA 17,394 $426.3k0.41% 0.41% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 15.2k, Q2 2026 17.4k +2.2k +2,184 14.4%
90 TERADYNE INC COM TER TER 878 $424.8k0.41% 0.41% ReducedShares held: Q3 2025 —, Q4 2025 1.0k, Q1 2026 2.0k, Q2 2026 878 -1.1k -1,138 -56.5%
91 ARROW ELECTRS INC COM ARW ARW 1,976 $421.7k0.40% 0.40% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 2.3k, Q2 2026 2.0k -344 -344 -14.8%
92 INGLES MKTS INC CL A IMKTA IMKTA 4,734 $419.3k0.40% 0.40% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 4.7k
93 ERASCA INC COM ERAS ERAS 22,460 $411.5k0.39% 0.39% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 33.1k, Q2 2026 22.5k -10.6k -10,610 -32.1%
94 VIANT TECHNOLOGY INC COM CL A DSP DSP 31,880 $403.6k0.39% 0.39% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 31.9k
95 QUALCOMM INC COM QCOM QCOM 2,161 $399.3k0.38% 0.38% NewShares held: Q3 2025 —, Q4 2025 7.0k, Q1 2026 0, Q2 2026 2.2k
96 SHATTUCK LABS INC COM STTK STTK 57,231 $397.2k0.38% 0.38% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 13.4k, Q2 2026 57.2k +43.9k +43,853 327.8%
97 ZURA BIO LTD CLASS A ORD SHS ZURA ZURA 66,919 $394.8k0.38% 0.38% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 97.1k, Q2 2026 66.9k -30.2k -30,183 -31.1%
98 LAM RESEARCH CORP COM NEW LRCX LRCX 893 $387.0k0.37% 0.37% ReducedShares held: Q3 2025 —, Q4 2025 15.5k, Q1 2026 5.2k, Q2 2026 893 -4.3k -4,270 -82.7%
99 SAVARA INC COM SVRA SVRA 61,759 $380.4k0.36% 0.36% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 128.4k, Q2 2026 61.8k -66.6k -66,617 -51.9%
100 MAZE THERAPEUTICS INC COM MAZE MAZE 12,618 $376.5k0.36% 0.36% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 12.6k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
STATE STR CORP STT STT 16,665 $2.1m16.7k shares
AUTOHOME INC ATHM ATHM 121,317 $2.1m121.3k shares
CAL MAINE FOODS INC CALM CALM 24,637 $2.0m24.6k shares
AXSOME THERAPEUTICS INC AXSM AXSM 5,971 $1.0m6.0k shares
CHEVRON CORP NEW CVX CVX 4,525 $936.2k4.5k shares
NGL ENERGY PARTNERS LP NGL NGL 70,000 $863.1k70.0k shares
TERNS PHARMACEUTICALS INC 13,301 $701.2k13.3k shares
GENERAL MTRS CO GM GM 9,207 $685.9k9.2k shares
DECKERS OUTDOOR CORP DECK DECK 6,708 $671.4k6.7k shares
NEW YORK TIMES CO NYT NYT 7,509 $628.7k7.5k shares
HCI GROUP INC HCI HCI 3,737 $577.8k3.7k shares
ASA GOLD AND PRECIOUS MTLS L ASA ASA 9,081 $563.3k9.1k shares
ISHARES TR HYG HYG 7,070 $562.5k7.1k shares
GRAVITY CO LTD GRVY GRVY 8,919 $552.6k8.9k shares
NEWMONT CORP NEM NEM 4,923 $532.9k4.9k shares
EMBECTA CORP EMBC EMBC 55,000 $486.2k55.0k shares
ACADEMY SPORTS & OUTDOORS IN ASO ASO 8,500 $479.8k8.5k shares
MILLROSE PPTYS INC MRP MRP 17,122 $479.4k17.1k shares
MIAMI INTL HLDGS INC MIAX MIAX 12,282 $478.0k12.3k shares
SMART SH GLOBAL LTD EM EM 408,078 $461.1k408.1k shares
TARSUS PHARMACEUTICALS INC TARS TARS 6,328 $443.9k6.3k shares
AVNET INC AVT AVT 6,702 $413.0k6.7k shares
CVS HEALTH CORP CVS CVS 5,700 $409.4k5.7k shares
BORGWARNER INC BWA BWA 7,269 $394.4k7.3k shares
AXOGEN INC AXGN AXGN 11,507 $381.2k11.5k shares